Cosibelimab Alternatives Compared
| Cosibelimab | Cetuximab | Keytruda (pembrolizumab) |
|
|---|
| Cosibelimab | Cetuximab | Keytruda (pembrolizumab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Squamous Cell Carcinoma. Cosibelimab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Head and Neck Cancer, Colorectal Cancer, Squamous Cell Carcinoma, Non Small Cell Lung Cancer, Pancreatic Cancer. Cetuximab may also be used for purposes not listed in this medication guide. View more |
Prescription only
Keytruda is an immunotherapy treatment called a checkpoint inhibitor that helps your immune system fight cancer and is used to treat many different types of cancer in adults and children including... View more |
Related suggestions Squamous Cell Carcinoma
|
|||||||
| More about Cosibelimab | More about Cetuximab | More about Keytruda (pembrolizumab) | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Cetuximab has an average rating of 7.1 out of 10 from a total of 10 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 10% reported a negative effect. |
Keytruda has an average rating of 4.9 out of 10 from a total of 254 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 48% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Cetuximab side effects |
View all Keytruda side effects |
|||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Keytruda prices |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
N/A |
|
||||||||
| Brand Names | ||||||||||
| Unloxcyt | Erbitux |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
427.2 hours |
213 hours |
624 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 604 drugs are known to interact with Cosibelimab:
|
A total of 21 drugs are known to interact with Cetuximab:
|
A total of 589 drugs are known to interact with Keytruda:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| First Approval Date | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
|
||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Libtayo
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell ...
Erbitux
Erbitux (cetuximab) is used to treat cancers of the colon and rectum. Learn about side effects ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Blenoxane
Blenoxane is used for hodgkin's lymphoma, non-hodgkin's lymphoma, squamous cell carcinoma ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.